{"id":4611,"date":"2024-06-20T15:31:34","date_gmt":"2024-06-20T13:31:34","guid":{"rendered":"https:\/\/avextra.com\/?p=4611"},"modified":"2024-06-20T15:31:35","modified_gmt":"2024-06-20T13:31:35","slug":"avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development","status":"publish","type":"post","link":"https:\/\/avextra.com\/en\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/","title":{"rendered":"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development"},"content":{"rendered":"

Bensheim, Germany, 20 June 2024<\/strong> \u2013 The leading European manufacturer and developer of Cannabis-based medicines Avextra AG (\u201cAvextra, <\/strong>\u201d), is proud to announce a strategic partnership in drug development with SynQube GmbH based in Offenbach, Germany. SynQube GmbH is led by the founders of THC Pharm Christian Steup and Holger R\u00f6nitz, both pioneers in cannabinoid therapy in Europe with over 25 years of experience in pharmaceutical development and manufacturing of cannabinoid and other psychotropic substances.<\/p>\n\n\n\n

Read more<\/a><\/em><\/strong><\/p>","protected":false},"excerpt":{"rendered":"

Avextra and SynQube jointly announce their strategic partnership. Both partners are combining their extensive expertise in the field of cannabinoid therapy to improve patient care and fulfill the requirements for reimbursement.<\/p>","protected":false},"author":1,"featured_media":4608,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"einzelbeitrag-ohne-bild","format":"standard","meta":{"inline_featured_image":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[9],"tags":[],"yoast_head":"\nAvextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development - Cannabisbasierte Arzneimittel von Avextra<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/avextra.com\/en\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development - Cannabisbasierte Arzneimittel von Avextra\" \/>\n<meta property=\"og:description\" content=\"Avextra and SynQube jointly announce their strategic partnership. Both partners are combining their extensive expertise in the field of cannabinoid therapy to improve patient care and fulfill the requirements for reimbursement.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/avextra.com\/en\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Cannabisbasierte Arzneimittel von Avextra\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-20T13:31:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-20T13:31:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1285\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MHorn\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MHorn\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/\"},\"author\":{\"name\":\"MHorn\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/person\/7006cb73df866f43e6989b07577ecc43\"},\"headline\":\"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development\",\"datePublished\":\"2024-06-20T13:31:34+00:00\",\"dateModified\":\"2024-06-20T13:31:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/\"},\"wordCount\":85,\"publisher\":{\"@id\":\"https:\/\/avextra.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg\",\"articleSection\":[\"english\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/\",\"url\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/\",\"name\":\"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development - Cannabisbasierte Arzneimittel von Avextra\",\"isPartOf\":{\"@id\":\"https:\/\/avextra.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg\",\"datePublished\":\"2024-06-20T13:31:34+00:00\",\"dateModified\":\"2024-06-20T13:31:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#primaryimage\",\"url\":\"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg\",\"contentUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg\",\"width\":1920,\"height\":1285},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/avextra.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/avextra.com\/#website\",\"url\":\"https:\/\/avextra.com\/\",\"name\":\"Cannabisbasierte Arzneimittel von Avextra\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/avextra.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/avextra.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/avextra.com\/#organization\",\"name\":\"Avextra Pharma GmbH\",\"url\":\"https:\/\/avextra.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg\",\"contentUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg\",\"caption\":\"Avextra Pharma GmbH\"},\"image\":{\"@id\":\"https:\/\/avextra.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/avextra-ag\/\",\"https:\/\/www.xing.com\/pages\/avextra\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/person\/7006cb73df866f43e6989b07577ecc43\",\"name\":\"MHorn\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/446d07f04c2eb204a64dbbc0313e10c7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/446d07f04c2eb204a64dbbc0313e10c7?s=96&d=mm&r=g\",\"caption\":\"MHorn\"},\"sameAs\":[\"https:\/\/dev.studio-horn.de\/staging\/avextra\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development - Cannabisbasierte Arzneimittel von Avextra","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/avextra.com\/en\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/","og_locale":"en_US","og_type":"article","og_title":"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development - Cannabisbasierte Arzneimittel von Avextra","og_description":"Avextra and SynQube jointly announce their strategic partnership. Both partners are combining their extensive expertise in the field of cannabinoid therapy to improve patient care and fulfill the requirements for reimbursement.","og_url":"https:\/\/avextra.com\/en\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/","og_site_name":"Cannabisbasierte Arzneimittel von Avextra","article_published_time":"2024-06-20T13:31:34+00:00","article_modified_time":"2024-06-20T13:31:35+00:00","og_image":[{"width":1920,"height":1285,"url":"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg","type":"image\/jpeg"}],"author":"MHorn","twitter_card":"summary_large_image","twitter_misc":{"Written by":"MHorn","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#article","isPartOf":{"@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/"},"author":{"name":"MHorn","@id":"https:\/\/avextra.com\/#\/schema\/person\/7006cb73df866f43e6989b07577ecc43"},"headline":"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development","datePublished":"2024-06-20T13:31:34+00:00","dateModified":"2024-06-20T13:31:35+00:00","mainEntityOfPage":{"@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/"},"wordCount":85,"publisher":{"@id":"https:\/\/avextra.com\/#organization"},"image":{"@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg","articleSection":["english"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/","url":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/","name":"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development - Cannabisbasierte Arzneimittel von Avextra","isPartOf":{"@id":"https:\/\/avextra.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#primaryimage"},"image":{"@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg","datePublished":"2024-06-20T13:31:34+00:00","dateModified":"2024-06-20T13:31:35+00:00","breadcrumb":{"@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#primaryimage","url":"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg","contentUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01.jpg","width":1920,"height":1285},{"@type":"BreadcrumbList","@id":"https:\/\/avextra.com\/2024\/06\/avextra-ag-and-synqube-gmbh-announce-a-strategic-partnership-in-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/avextra.com\/"},{"@type":"ListItem","position":2,"name":"Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development"}]},{"@type":"WebSite","@id":"https:\/\/avextra.com\/#website","url":"https:\/\/avextra.com\/","name":"Cannabisbasierte Arzneimittel von Avextra","description":"","publisher":{"@id":"https:\/\/avextra.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/avextra.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/avextra.com\/#organization","name":"Avextra Pharma GmbH","url":"https:\/\/avextra.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/avextra.com\/#\/schema\/logo\/image\/","url":"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg","contentUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg","caption":"Avextra Pharma GmbH"},"image":{"@id":"https:\/\/avextra.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/avextra-ag\/","https:\/\/www.xing.com\/pages\/avextra"]},{"@type":"Person","@id":"https:\/\/avextra.com\/#\/schema\/person\/7006cb73df866f43e6989b07577ecc43","name":"MHorn","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/avextra.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/446d07f04c2eb204a64dbbc0313e10c7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/446d07f04c2eb204a64dbbc0313e10c7?s=96&d=mm&r=g","caption":"MHorn"},"sameAs":["https:\/\/dev.studio-horn.de\/staging\/avextra"]}]}},"author_meta":{"display_name":"MHorn","author_link":"https:\/\/avextra.com\/en\/author\/mhorn\/"},"featured_img":"https:\/\/avextra.com\/wp-content\/uploads\/2024\/06\/Vorschaubild_Pressemitteilung_Partnership-SynQube-01-300x201.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/avextra.com\/en\/category\/english\/\" class=\"advgb-post-tax-term\">english<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">english<\/span>"]}},"comment_count":0,"relative_dates":{"created":"Posted 2 years ago","modified":"Updated 2 years ago"},"absolute_dates":{"created":"Posted on 20. June 2024","modified":"Updated on 20. June 2024"},"absolute_dates_time":{"created":"Posted on 20. June 2024 15:31","modified":"Updated on 20. June 2024 15:31"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/posts\/4611"}],"collection":[{"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/comments?post=4611"}],"version-history":[{"count":2,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/posts\/4611\/revisions"}],"predecessor-version":[{"id":4613,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/posts\/4611\/revisions\/4613"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/media\/4608"}],"wp:attachment":[{"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/media?parent=4611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/categories?post=4611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/tags?post=4611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}